Roche Evades Cancer Study Stock-Drop Suit For Second Time
Swiss pharmaceutical company Roche Holding AG escaped, for the second time, a proposed class action accusing it and four executives of misleading investors about the results of a breast cancer study...To view the full article, register now.
Already a subscriber? Click here to view full article